(Q36641166)

English

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours

scientific article published on September 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours (English)

1 reference

Europe PubMed Central

15 August 2017

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Alexopoulos CG

1

1 reference

Europe PubMed Central

15 August 2017

Vaslamatzis M

2

1 reference

Europe PubMed Central

15 August 2017

Hatzidimitriou G

3

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

1 September 1999

1 reference

Europe PubMed Central

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

15 August 2017

81

1 reference

Europe PubMed Central

15 August 2017

1

1 reference

Europe PubMed Central

15 August 2017

69-74

1 reference

Europe PubMed Central

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690652

0 references

Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374347

30 September 2017

Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987-1991.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374347

28 June 2018

Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374347

28 June 2018

Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/10487614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/10487614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690652

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690652

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJC.6690652

1 reference

Europe PubMed Central

15 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36641166&oldid=2098498955"